Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
mCombriax (mRNA-1083) Influenza/COVID-19 Vaccine in Adults ≥ 65 Years
NCT07790523Phase 4Not yet recruiting
- Start
- Sep 2026
- Primary completion
- May 2028
- Countries
- 2
01
Overview
A Phase 4 trial of mCOMBRIAX in coronavirus disease 2019 (COVID-19), influenza. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
mCOMBRIAX
03
Conditions
coronavirus disease 2019 (COVID-19)influenza
Beyond the preview
Go deeper on NCT07790523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07790523.